ID   SKG-I
AC   CVCL_2793
SY   SKG-1; SKG1; SKGI
DR   BioSample; SAMN03472778
DR   Cell_Model_Passport; SIDM01853
DR   Cosmic; 877459
DR   Cosmic; 1152537
DR   DepMap; ACH-001651
DR   JCRB; IFO50308
DR   Wikidata; Q54954725
RX   CelloPub=CLPUB00481;
RX   PubMed=3029293;
RX   PubMed=6163305;
RX   PubMed=6174649;
RX   PubMed=7196935;
RX   PubMed=9436037;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 35-42 hours (PubMed=7196935).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Deep exome analysis.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): DepMap; JCRB
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 10
ST   D18S51: 15
ST   D21S11: 29,30
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 17
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 22
//
RX   CelloPub=CLPUB00481;
RA   Kuno H., Yoshida T.;
RT   "Detection of human papillomavirus types 16, 18, and 33 in cell lines
RT   derived from human genital organs by polymerase chain reaction.";
RL   Res. Commun. Inst. Ferment. Osaka 18:6-12(1997).
//
RX   PubMed=3029293; DOI=10.1099/0022-1317-68-2-583;
RA   Shirasawa H., Tomita Y., Sekiya S., Takamizawa H., Simizu B.;
RT   "Integration and transcription of human papillomavirus type 16 and 18
RT   sequences in cell lines derived from cervical carcinomas.";
RL   J. Gen. Virol. 68:583-591(1987).
//
RX   PubMed=6163305;
RA   Sekiya S., Takamizawa H.;
RT   "Effect of anticancer drugs on in vitro survival of cell lines derived
RT   from various gynecologic tumors.";
RL   Nihon Sanka Fujinka Gakkai Zasshi 33:373-376(1981).
//
RX   PubMed=6174649;
RA   Sekiya S., Kawata M., Inaba N., Takamizawa H.;
RT   "Studies on marker substances in cell lines derived from various human
RT   gynecologic tumors.";
RL   Nihon Sanka Fujinka Gakkai Zasshi 34:37-42(1982).
//
RX   PubMed=7196935;
RA   Taguchi S.;
RT   "Establishment and characterization of the human uterine cervical
RT   epidermoid cancer cell line.";
RL   Nihon Sanka Fujinka Gakkai Zasshi 33:1180-1188(1981).
//
RX   PubMed=9436037;
RA   Soma M., Ishiwata I., Ishiwata C., Nakaguchi T., Ono I., Kiguchi K.,
RA   Hashimoto H., Tachibana T., Ishikawa H., Nozawa S.;
RT   "Tissue reconstruction of gynecologic tumor cells in the rotation
RT   culture system.";
RL   Hum. Cell 10:175-181(1997).
//